Tampa, FL - April 15, 2024- Revelation Pharma, a leading national network of 503A and 503B compounding pharmacies dedicated to delivering innovative, high quality, and customized medications and services, proudly announces Brad Leach as their new Senior Vice President, 503B.
With over three decades of acute care experience, including more than 25 years dedicated to the compounding pharmacy industry, Mr. Leach brings a wealth of knowledge garnered from Fortune 500 healthcare corporations to PE-backed organizations. His extensive expertise has been honed through adept navigation of regulatory shifts, evolving from pre-797 regulations to today’s dynamic 503B market landscape.
Recognized for driving commercial growth and operational excellence, Mr. Leach boasts a proven track record of effectively building and leading teams to success. His multifaceted skill set spans business strategy, marketing, customer service, and new product development.
Prior to joining Revelation